Sabra Healthcare REIT (NASDAQ:SBRA) Issues Earnings Results, Misses Estimates By $0.05 EPS

Key Points

• Sabra Healthcare REIT reported quarterly EPS of $0.11, missing the $0.16 analyst consensus by $0.05. Revenue reached $246.34 million, exceeding estimates of $236.64 million.
• Shares traded near $19.72, with the company valued at approximately $5.04 billion. The stock’s 52-week range is $17.53 to $22.77.
• Analysts maintain a “Moderate Buy” consensus with a $21.50 price target, while CEO Richard Matros sold 200,000 shares under a pre-arranged Rule 10b5-1 trading plan.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) issued its quarterly earnings data on Monday. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.16 by ($0.05), FiscalAI reports. The company had revenue of $246.34 million for the quarter, compared to the consensus estimate of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock traded down $0.02 on Monday, hitting $19.72. The company had a trading volume of 3,358,445 shares, compared to its average volume of 2,663,508. The business has a 50-day simple moving average of $19.87 and a 200-day simple moving average of $19.96. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The company has a market cap of $5.04 billion, a PE ratio of 75.85, a PEG ratio of 1.79 and a beta of 0.63. Sabra Healthcare REIT has a 52 week low of $17.53 and a 52 week high of $22.77.

Wall Street Analyst Weigh In

SBRA has been the subject of several recent research reports. Weiss Ratings lowered shares of Sabra Healthcare REIT from a "hold (c+)" rating to a "hold (c)" rating in a research report on Thursday, October 8th. Citigroup reiterated a "market outperform" rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. UBS Group reduced their target price on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set a "neutral" rating for the company in a research note on Tuesday, October 13th. Raymond James Financial raised shares of Sabra Healthcare REIT from an "underperform" rating to a "market perform" rating in a research note on Thursday, August 6th. Finally, Citizens Jmp raised their price target on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a "market outperform" rating in a research note on Wednesday, July 22nd. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, Sabra Healthcare REIT presently has a consensus rating of "Moderate Buy" and a consensus price target of $21.50.

Insider Buying and Selling

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the company's stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is currently owned by insiders.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.